/Gilead extends Yale collaboration; GSK trial data spurs research;
NEWS

Gilead extends Yale collaboration; GSK trial data spurs research;

FierceBiotech
2014/10/27

Gilead ($GILD) extended its genomics cancer collaboration with the Yale School of Medicine. News

A study found GlaxoSmithKline's ($GSK) trial data-sharing policy has supported new analyses. Article

Rideshare service Uber used its IT infrastructure for a flu vaccine delivery service. Blog | More

Veeva Systems ($VEEV) struck a deal to supply its eTMF platform to inVentiv Health Clinical. Post

Connecticut loaned the Icahn School of Medicine $9.5 million to set up a genomics facility. Item (reg. req.)

Researchers used supercomputers to tie proteins to side effects. Release

The Jackson Laboratory received a $10 million gift to establish a computational biology center. More

Summary

> Gilead (GILD)extendeditsgenomicscancercollaborationwiththeYaleSchoolofMedicine.News>AstudyfoundGlaxoSmithKline′s(GSK) trial data-sharing policy has supported new...